Could an HIV drug stop anal cancer before it starts?
NCT ID NCT05334004
Summary
This early-stage study is testing the safety of a topical version of an HIV medication (lopinavir/ritonavir) applied inside the anus. The goal is to see if it can treat high-grade anal precancer (AIN 2/3) in people living with HIV, which can develop into anal cancer. Researchers will first find the safest dose and then check if the treatment helps clear the precancer and the HPV virus that causes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE ANAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UW Digestive Health Center Anoscopy Clinic
RECRUITINGMadison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.